{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T04:19:28Z","timestamp":1792556368041,"version":"4.5.0"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1097\/ede.0b013e31819d8d3f","type":"journal-article","created":{"date-parts":[[2009,6,12]],"date-time":"2009-06-12T07:10:09Z","timestamp":1244790609000},"page":"604-610","source":"Crossref","is-referenced-by-count":53,"title":["Uterine Leiomyomata in Relation to Insulin-like Growth Factor-I, Insulin, and Diabetes"],"prefix":"10.1097","volume":"20","author":[{"given":"Donna D.","family":"Baird","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg","family":"Travlos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Dunson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimee A.","family":"D'Aloisio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie J.","family":"London","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel M.","family":"Schectman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-21-20210207","first-page":"229","article-title":"Hysterectomy rates in the United States 1990-1997.","volume":"99","author":"Farquhar","year":"2002","journal-title":"Obstet Gynecol"},{"key":"R3-21-20210207","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000292336","article-title":"Clonal determination of uterine leiomyomas by analyzing differential inactivation of the X-chromosome-linked phosphoglycerokinase gene.","volume":"40","author":"Hashimoto","year":"1995","journal-title":"Gynecol Obstet Invest"},{"key":"R4-21-20210207","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1136\/bmj.293.6543.359","article-title":"Risk factors for uterine fibroids: reduced risk associated with oral contraceptives.","volume":"293","author":"Ross","year":"1986","journal-title":"BMJ"},{"key":"R5-21-20210207","article-title":"Women and Health.","author":"Schwartz","year":"2000"},{"key":"R6-21-20210207","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/molehr\/gah174","article-title":"Estrogen-induced changes in IGF-I, Myb family, and MAP kinase pathway genes in human uterine leiomyoma and normal uterine smooth muscle cell lines.","volume":"11","author":"Swartz","year":"2005","journal-title":"Mol Hum Reprod"},{"key":"R7-21-20210207","first-page":"3","article-title":"Insulin-like growth factors and their binding proteins: biological actions.","volume":"16","author":"Jones","year":"1995","journal-title":"Endocr Rev"},{"key":"R8-21-20210207","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/mrd.1080270203","article-title":"Expression of the insulin-like and platelet-derived growth factor genes in human uterine tissues.","volume":"27","author":"Boehm","year":"1990","journal-title":"Mol Reprod Dev"},{"key":"R9-21-20210207","first-page":"1106","article-title":"Messenger ribonucleic acid expression of the insulin-like growth factors and their binding proteins in uterine fibroids and myometrium.","volume":"76","author":"Vollenhoven","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"R10-21-20210207","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1093\/oxfordjournals.humrep.a137937","article-title":"Insulin-like growth factor (IGF), IGF binding protein (IGFBP), and IGF receptor gene expression and IFGBP synthesis in human uterine leiomyomata.","volume":"8","author":"Giudice","year":"1993","journal-title":"Hum Reprod"},{"key":"R11-21-20210207","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1038\/bjc.1997.278","article-title":"Expression of insulin-like growth factors (IGFs), their receptors and IGF binding protein-3 in normal, benign and malignant smooth muscle tissues.","volume":"75","author":"Van Der Ven","year":"1997","journal-title":"Br J Cancer"},{"key":"R12-21-20210207","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/molehr\/6.10.915","article-title":"Gene expression and tissue concentrations of IGF-I in human myometrium and fibroids under different hormonal conditions.","volume":"6","author":"Englund","year":"2000","journal-title":"Mol Hum Reprod"},{"key":"R13-21-20210207","first-page":"359","article-title":"An accumulation of insulin-like growth factor I (IGF-I) in human myometrium and uterine leiomyomas in various stages of tumor growth.","volume":"15","author":"Wolanska","year":"2004","journal-title":"Eur Cytokine Netw"},{"key":"R14-21-20210207","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.taap.2004.10.007","article-title":"Regulation of IGF-I production and proliferation of human leiomyomal smooth muscle cells by Scutellaria barbata D. Don in vitro: isolation of flavanoids of apigenin and luteolin as acting compounds.","volume":"205","author":"Kim","year":"2005","journal-title":"Toxicol Appl Pharmacol"},{"key":"R15-21-20210207","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.fertnstert.2005.01.142","article-title":"Expression profile of the tumorigenic factors associated with tumor size and sex steroid hormone status in uterine leiomyomata.","volume":"84","author":"Wei","year":"2005","journal-title":"Fertil Steril"},{"key":"R16-21-20210207","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/modpathol.3800283","article-title":"Expression profile of tuberin and some potential tumorigenic factors in 60 patients with uterine leiomyomata.","volume":"18","author":"Wei","year":"2005","journal-title":"Mod Pathol"},{"issue":"S5","key":"R17-21-20210207","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1289\/ehp.00108s5795","article-title":"Immunohistochemical localization of growth factors and their receptors in uterine leiomyomas and matched myometrium.","volume":"108","author":"Dixon","year":"2000","journal-title":"Environ Health Perspect"},{"key":"R18-21-20210207","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1677\/joe.0.1720083","article-title":"Dysregulation of IGF-I signaling in uterine leiomyoma.","volume":"172","author":"Burroughs","year":"2002","journal-title":"J Endocrinol"},{"key":"R19-21-20210207","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/ijc.2910590323","article-title":"Growth advantage of human leiomyoma cells compared to normal smooth-muscle cells due to enhanced sensitivity toward insulin-like growth factor I.","volume":"59","author":"Van Der Ven","year":"1994","journal-title":"Int J Cancer"},{"key":"R20-21-20210207","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/0002-9378(95)91420-X","article-title":"Insulin-like growth factor I promotes leiomyoma cell growth in vitro.","volume":"172","author":"Strawn","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"R21-21-20210207","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1677\/erc.1.01219","article-title":"Insulin-like growth factor (IGF)-I, IGF binding protein-3, and breast cancer risk: 8 years on.","volume":"13","author":"Renehan","year":"2006","journal-title":"Endocr Relat Cancer"},{"key":"R22-21-20210207","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1158\/1055-9965.EPI-06-0960","article-title":"Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer.","volume":"16","author":"Baglietto","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R23-21-20210207","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0015-0282(16)56635-7","article-title":"Plasma insulin-like growth factor-I, CA-125, estrogen, and progesterone in women with leiomyomas.","volume":"61","author":"Dawood","year":"1994","journal-title":"Fertil Steril"},{"key":"R24-21-20210207","first-page":"29","article-title":"Affect of insulin-like growth factor I and estradiol on the growth of uterine leiomyoma.","volume":"24","author":"Huang","year":"1999","journal-title":"Hunan Yi Ke Da Xue Xue Bao"},{"key":"R25-21-20210207","first-page":"801","article-title":"Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions.","volume":"18","author":"Rajaram","year":"1997","journal-title":"Endocr Rev"},{"key":"R26-21-20210207","first-page":"3629","article-title":"Modulation of insulin-like growth factor (IGF) action by IGF-binding proteins in normal, benign, and malignant smooth muscle tissues.","volume":"81","author":"Van Der Ven","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"R27-21-20210207","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/aje\/153.1.11","article-title":"Szklo M, Rosenshein NB. Risk factors for uterine leiomyoma: a practice-based case-control study II. Atherogenic risk factors and potential sources of uterine irritation.","volume":"153","author":"Faerstein","year":"2001","journal-title":"Am J Epidemiol"},{"key":"R28-21-20210207","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1042\/bst0290513","article-title":"Specificity in ligand binding and intracellular signaling by insulin and insulin-like growth factor receptors.","volume":"29","author":"Siddle","year":"2001","journal-title":"Biochem Soc Trans"},{"key":"R29-21-20210207","first-page":"36","article-title":"Growth potential of human uterine leiomyomas: some in vitro observations and their implications.","volume":"66","author":"Cramer","year":"1985","journal-title":"Obstet Gynecol"},{"key":"R30-21-20210207","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1210\/edrv-8-2-132","article-title":"The gonadotropic function of insulin.","volume":"8","author":"Poretsky","year":"1987","journal-title":"Endocr Rev"},{"key":"R31-21-20210207","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mob.2003.99","article-title":"High incidence of uterine leiomyoma: ultrasound evidence.","volume":"188","author":"Baird","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R32-21-20210207","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.0006-341X.2002.00813.x","article-title":"Bayesian modeling of incidence and progression of disease from cross-sectional data.","volume":"58","author":"Dunson","year":"2002","journal-title":"Biometrics"},{"key":"R33-21-20210207","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/aje\/kwj363","article-title":"Physical activity is associated with reduced uterine leiomyoma incidence.","volume":"165","author":"Baird","year":"2007","journal-title":"Am J Epidemiol"},{"key":"R34-21-20210207","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/aje\/kwi188","article-title":"Easy SAS calculations for risk or prevalence ratios and differences.","volume":"162","author":"Spiegelman","year":"2005","journal-title":"Am J Epidemiol"},{"key":"R35-21-20210207","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.fertnstert.2006.11.012","article-title":"Polycystic ovary syndrome and risk of uterine leiomyomata.","volume":"87","author":"Wise","year":"2007","journal-title":"Fertil Steril"},{"key":"R36-21-20210207","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1159\/000066230","article-title":"The role of the IGF system in cancer: from basic to clinical studies and clinical applications.","volume":"63","author":"Moschos","year":"2002","journal-title":"Oncology"},{"key":"R37-21-20210207","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1158\/1055-9965.607.13.4","article-title":"Insulin-like growth factors, insulin-like growth factor-binding proteins, and endometrial cancer in postmenopausal women: results from a US case-control study.","volume":"13","author":"Lacey","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R38-21-20210207","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2174\/138920106776597621","article-title":"The role of insulin-like growth factor I components in the regulation of vitamin D.","volume":"7","author":"Gomez","year":"2006","journal-title":"Curr Pharm Biotechnol"},{"key":"R39-21-20210207","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.2337\/diacare.22.11.1839","article-title":"Specific fiber deficits in sensorimotor diabetic polyneuropathy correspond to cytotoxicity against neuroblastoma cells of sera from patients with diabetes.","volume":"22","author":"Pittenger","year":"1999","journal-title":"Diabetes Care"},{"key":"R40-21-20210207","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1158\/1055-9965.EPI-05-0848","article-title":"Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2- to 3-year period.","volume":"15","author":"Missmer","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R41-21-20210207","first-page":"496","article-title":"Short-term within-person variability in clinical chemistry test results. Experience from the atherosclerosis risk in communities study.","volume":"118","author":"Eckfeldt","year":"1994","journal-title":"Arch Pathol Lab Med"}],"container-title":["Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/EDE.0b013e31819d8d3f","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:55:06Z","timestamp":1786038906000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001648-200907000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/ede.0b013e31819d8d3f","relation":{},"ISSN":["1044-3983"],"issn-type":[{"value":"1044-3983","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}